Taken together, our pan-cancer analyses revealed correlations between FBXO22 expression, methylation, mutation and clinical prognosis, and immune cell infiltration, which contribute to a better understanding of the role of FBXO22 in tumorigenesis. The gene discussed is FBXO22; the disease is cancer.